The most plausible variables that may impact outcome in our patients include hypogammaglobulinemia, qualitative and quantitative B- and T-cell deficiencies, CD4 + lymphopenia, innate immune dysfunction, and neutropenia, all resulting from haematological malignancy itself and respective treatment [9, 27, 38]. The gene discussed is CD4; the disease is lymphopenia.